TOLERABILITY AND SAFETY OF RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES - A PROSPECTIVE LONGITUDINAL STUDY OVER 6 MONTHS.
- Resource Type
- Article
- Source
- Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p550-551, 2p
- Subject
- Language
- ISSN
- 00034967